相关实验视频
Updated: Jun 28, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.4K
儿科年龄对花生过敏的脱敏现状和进展
Simone Foti Randazzese1, Ilenia Panasiti1, Lucia Caminiti1
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.
概括
花生过敏影响全球儿童,口服免疫疗法显示出有希望但引起副作用. 像皮肤上免疫疗法这样的新方法为管理这种疾病提供了更好的安全性.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 儿科医学 儿科医学
- 胃肠病学 胃肠病学
背景情况:
- 全球儿童中花生过敏的患病率正在上升,影响1%-3%的儿科人口.
- 目前的指导方针建议早期引入花生,但缺乏具体的剂量和频率建议.
- 过敏原免疫疗法是改变花生过敏过程的主要治疗方法.
研究的目的:
- 审查对花生过敏的当前和新兴疗法.
- 为了比较不同免疫疗法途径的疗效和安全性.
- 突出正在研究的新型治疗策略.
主要方法:
- 审查现有的关于花生过敏治疗的文献.
- 对口服,舌下,皮下和皮下免疫疗法的临床试验数据的分析.
- 评估新兴疗法,包括生物制剂和益生菌.
主要成果:
- 口服免疫疗法显示出有效性,但具有显著的胃肠道副作用.
- 与口服免疫疗法相比,下舌免疫疗法使用的剂量较低,不良反应较少.
- 皮肤上免疫疗法具有很高的安全性;生物制剂和益生菌正在研究中.
结论:
- 花生过敏治疗正在迅速发展,有各种不同的免疫疗法选择.
- 优化免疫治疗耐受性和标准化方案是关键的研究领域.
- 生物制剂和益生菌等创新方法可能提供新的治疗途径.
相关概念视频
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Allergic Reactions
27.3K
Overview
27.3K
Hypersensitivities
622
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
622
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Behavior Therapy
48
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
48
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K

